HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pulmonary embolism as a first manifestation of synchronous occurrence of two neoplasms].

Abstract
A case of 67-year-old man with a first episode of acute, unprovoked venous thromboembolism (VTE). Screening for cancer revealed coexistence of two neoplasms: colon sigmoid cancer (operated on 6 weeks after pulmonary embolism onset), and multiple myeloma (treated successfully with thalidomide and dexamethasone). Low molecular weight heparin use as VTE treatment was followed by thromboprophylaxis for myeloma therapy. During a 30-month follow-up period, neither new thromboembolic complications nor cancer recurrence were observed. Overlapping different prothrombotic mechanisms of double malignancy might result in detection of both neoplasms at early stage.
AuthorsWaldemar Elikowski, Maria Lewandowska, Małgorzata Małek, Piotr Krokowicz, Grazyna Piotrowska-Stelmaszyk, Krystyna Zawilska
JournalKardiologia polska (Kardiol Pol) Vol. 67 Issue 11 Pg. 1262-6; discussion 1267 (Nov 2009) ISSN: 0022-9032 [Print] Poland
Vernacular TitleZatorowość płucna jako pierwszy objaw synchronicznego zachorowania na dwa nowotwory.
PMID20024855 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Heparin, Low-Molecular-Weight
  • Thalidomide
  • Dexamethasone
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Colonic Neoplasms (complications, diagnosis)
  • Dexamethasone (therapeutic use)
  • Heparin, Low-Molecular-Weight (therapeutic use)
  • Humans
  • Male
  • Multiple Myeloma (complications, diagnosis, drug therapy)
  • Neoplasms, Second Primary (complications, diagnosis)
  • Pulmonary Embolism (diagnosis, etiology)
  • Thalidomide (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: